The discovery of genetic drivers of cancer can have critical implications for the diagnosis and treatment of cancer patients, yet genome analysis has focused primarily on only 1-2% of the whole genome - the part that contains the code for making proteins. What about the rest? Does it also play a role in driving the disease?
As part of the Pan-Cancer project, scientists have analysed whole-genome sequencing data. To do this, the scientists had to develop new statistical methods suitable for analysing the non-coding genome.
The author explains the rationale for the investigation: "Decades of work has been focused on identifying the consequences of changes in the protein-coding part of the genome. Many cancers have no important mutations in the protein-coding part, but something is driving the cancer. By inference, we suspect the non-coding part is playing an important role in these unexplained cases."
The analysis focused on identifying driver point mutations - mutations that affect only one or very few letters of the DNA code - and structural variants, or rearrangements, in the non-coding regions of the genome. In addition to identifying new drivers, the analysis confirmed some previously reported drivers and, importantly, invalidated others. It also identified novel putative driver rearrangements near genes called the AKR1C genes. This correlated with increased gene expression across lung and liver cancers.
Mutations and structural variants driving cancer were found to be less frequent in non-coding genes and sequences than in the protein-coding part of the genome, but this could partly be due to the relatively small number of patient datasets available to analyse for some tumor types. "We probably need an order of magnitude more genomes to really have a comprehensive understanding of all the mutations that drive cancer, and the complex mechanisms by which they form," says the author. "As cancer is a disease of the genome, we ultimately want to be able to explain as many cancers as possible using genetics."
Thanks in large part to the work carried out during the Pan-Cancer project, about 95% of the cancers studied could be explained genetically by a driver mutation. One of the key outputs of the project is a catalogue that clinicians and researchers can use to look up specific tumor types and identify the drivers of the disease.
https://news.embl.de/science/pan-cancer-cancer-drivers/
https://www.nature.com/articles/s41586-019-1913-9
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fpatterns-of-somatic&filter=22
New genetic drivers of cancer identified!
- 3,446 views
- Added
Edited
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Protecting genetic privacy in research
Read more
How melatonin promotes sleep
Read more
Neuronal uptake of amyloid beta in Alzheimer's disease
Read more
A novel monoclonal antibody therapy in a phase 2 trail cuts LDL cho…
Read more
Pituitary peptide modulates alcohol dependence and anxiety-like beh…
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar